Akhil C Banerjea
Chair
Virology Department
National Institute of Immunology
New Delhi, India
Akhil C. Banerjea, Ph.D. is currently a Senior Scientist/Chair of Virology Department at National Institute of Immunology, New Delhi, India. He is a member of the National Academy of Sciences, and Fellow of the Indian National Science Academy (INSA) India. Thomson Reuters recognized ACB as a distinguished expert and leader in Virology in 2011. He obtained his B.Sc. degree from Gorakhpur University, Masters degree in Microbiology from G. B. Pant University, Uttranchal and Ph.D. from National Institute of Virology, University of Pune in Virology. He was a Post Doctorate Fellow & Assistant Research Professor at Duke University Medical Center, Durham, North-Carolina, USA (1984 – 90) and Senior Staff-Fellow at National Institutes of Health, Bethesda, Maryland, USA (1990 – 1994). He has published more than 90 papers in international peer reviewed journals in the field of HIV/AIDS, Biochemistry, Gene Therapy, J. Virol., Retrovirology, PNAS (USA); Blood, Virology etc., and contributed 14 invited chapters/ reviews to National and International Publishers in the field of HIV/AIDS and Gene Therapy. He is the recipient of National Awards of ICMR (Shakuntala Amir Chand, 1982); National Foreign-Assocaiateship award of DBT, 1998, National Bio-Science Award for Career Development of DBT-2001, SR Scientist Indian Immunology Society Oration Award, 2012 of Government of India and won several full international scholarships to present his work on HIV-1 in USA, UK, South Africa, UK, Japan and Singapore.
He has guided 8 PhD students and trained >24 students, post docs etc. Some of his students are faculty in National Institutes of India or in Pharmaceutical Industries and some are pursuing advanced research in places like Yale, MIT, NIH, UCLA, JHU, etc. He is the recipient of Indo-US-NIH –ICMR grant on HIV transmission and several DBT, CSIR and ICMR extramural grants on HIV Pathogenesis. He is a Member- Editorial Board of several International Journals. He regularly reviews papers for Mol. Ther, Antiviral Research, Gene, JBC, Scientific Reports, Biochemical J, Virology on a regular basis. He is member of the several task forces of DBT and ICMR on HIV/AIDS. He has delivered seminars in Albert Einstein-NY, Duke-NC, UCLA-CA, COH-CA, NCI-NIH, Drexel-Philadelphia NSU-Singapore, Pasteur Inst. etc. He is interested in studying molecular basis of various viral diseases, especially HIV / AIDS and Influenza in India and develop catalytic nucleic acids based antiviral approaches. He was awarded the Visiting Professorship at Colorado State University, Fort-Collins, Colorado, USA for a period of two years (2002 – 2004). The work carried out on siRNA into stem cells against HIV-1 was covered in New York Times in 2003 and now in Clinical trial in USA. His major interest now is to use lentiviral vectors, stem cells, catalytic nucleic acids (Ribozymes & DNA-enzymes) and small interfering RNA/miRNA technology as a gene therapy approach against HIV and other pathogens on one hand and determine the functional implications of genetic changes in the host genes or viral genes of HIV-1 in order to understand the molecular basis of HIV/AIDS pathogenesis in India. The projects dealing with Microbiology, Epidemiology, Biochemistry, Virus infections, Epidemiology & Diagnostics, Gene Therapy, Cell Biology, Life Sciences, Stem Cell biology, Developmental Biology, RNAi/siRNA/microRNA technology in plants and animals, Biotechnology, National Programs on Immunizations, Vaccine Technologies etc have been evaluated by the candidate at National and International levels. Extensively involved in the Indo-US Vaccine Action programs – evaluated Indian & US project grants involved in HIV vaccine and pathogenesis.
His major interest now is to use lentiviral vectors, stem cells, catalytic nucleic acids (Ribozymes & DNA-enzymes) and small interfering RNA/miRNA technology as a gene therapy approach against HIV and other pathogens on one hand and determine the functional implications of genetic changes in the host genes or viral genes of HIV-1 in order to understand the molecular basis of HIV/AIDS pathogenesis in India.


Eduardo Seclén Hidalgo
Molecular Microbiology and Immunology
Keck School of Medicine
University of Southern California
Los Angeles
USA
I’m a Research Associate at the University of Southern California, where I work in in hematopoietic stem cells focused on HIV research. I obtained my PhD from the University of Complutense in Madrid, Spain studying ways to characterize HIV viral tropism, and its impact in the pathogenesis of the infection and response to antiretroviral treatment. In the last 3 years, my research have been enriched by my participation in projects using gene therapy in hematopoietic stem cells as an approach to fight HIV infection, aiming to a functional cure.
My research have been funded by prestigious fellowships provided by the AIDS foundation "Fundación de Investigación y Prevencióndel SIDA enEspaña", the National Health Institution "Instituto de Salud Carlos III" and, more recently, the "California Institute for Regenerative Medicine".
1. HIV virology
2. HIV tropism
3. HIV pathogenesis
4. Antiretroviral treatment, especially entry inhibitors
5. Bone marrow transplantation as approach to fight HIV
6. Gene therapy in stem cells as approach to fight infectious diseases, including HIV
7. HIV latency, especially use of vectors to disrupt latency in vivo and mouse models


George Nyandoro
Department of Community Medicine
College of Health Sciences
University of Zimbabwe
Zimbabwe
George Nyandoro was a Research Consultant (Biostatistics) for Development Data Institute (Non-Governmental International Organization).Currently He is a reviewer for the OMICS Group Journal ; Peak Journal of Public Health Management ;BMC Public health and Lead Guest Editor for Science PG ,Science Journal of Public Health (SJPH). He is affiliated with the University of Zimbabwe- UZCHS with more than 15 publications in various science and Medical disciplines. He stands as a Medical methodologies research consultant with a strong medical research background.
HIV, Communicable Diseases, Community Medicine


Stambullian Marcela
Department of Nutrition
The School of Medicine
University of Buenos Aires
Argentina
BA in Nutrition. PhD awarded by University of Buenos Aires (UBA) through a PhD scholarship. Since 2014, I have been attending a Specialization in Scientific Research Methodology.
In relation to my employment history, since 1999 to present, I am a graduate teaching assistant at the Department of Nutrition from the School of Medicine of University of Buenos Aires.
Also, I am a Junior Researcher at that University with a grant from the Scientific Programming (2014–2016) of the Department of Science and Technology. From 2004, I participated in 5 different researches, all of them included in the Scientific Programming of UBA, in the field of Nutrition and HIV.
Since 1998, I have been working as nutritionist in a private Institution specialized in HIV infection and AIDS. I have many publications, lectures and research papers presentations in Nutrition and HIV/AIDS.
Nutrition and Dietetics in HIV and AIDS


Namita Giri
Graduate Teaching and Research Assistant
Division of Pharmaceutical Sciences
School of Pharmacy
University of Missouri-Kansas City
USA
Namita Giri, a researcher in the field of Pharmaceutical Sciences born in central part of India. She has been in the pharmaceutical field for more than 14 years. She graduated with Bachelor of Pharmacy and Master of Pharmacy (Pharmaceutical biotechnology) from S.G.S.I.T.S Indore (India) and Dr. H.S Gour University, Sagar (India) respectively, both the institutes are among the premier institutes for Pharmacy education in India. After graduation she worked as assistant professor for two years and decide to pursue PhD. As of now, Namita is pursuing her interdisciplinary PhD in Pharmaceutical Science with chemistry as co-discipline at University of Kansas City, Missouri (United States of America). Her research interest are primarily focused on design and development of smart delivery systems for microbicides, Novel drug delivery systems, application of recent technological advances to pharmaceutical technology and nanotechnology.
Her research interest are primarily focused on design and development of smart delivery systems for microbicides, Novel drug delivery systems, application of recent technological advances to pharmaceutical technology and nanotechnology.


Rahul V. Patel
Scientist
Laboratory of Growth Regulators
Palacky University
Olomouc & Institute of Experimental Botany AS CR
The Czech Republic, Europe
This section will be updated soon...!
Research Field: Organic Synthesis and Drug Discovery
Synthesis of new heterocyclic scaffolds as well as natural products inspired semi-synthetic derivatives having antimicrobial, antioxidant and anticancer action.


Richard Ekorinyang
Health Program Officer
World Vision Uganda
Uganda
Profile: I am a medical professional and hold Master of Science degree in Health Services Management interested in research and further studies in doctoral studies. I am a subject matter specialist in Public Health with vast experience in HIV care and support as well as reproductive health. I have a lot of interest in issues to do with HIV and Reproductive Health.
My research interests are
1. HIV prevention and support
2. Reproductive Maternal Newborn and Child Health
3. Adolescent reproductive health, among others


M. Nia Madison
Assistant Professor
Department of Mathematics and Natural Sciences
Miami Dade College
Homestead Campus
USA
Dr. M.Nia Madison is a STEM advocate, science consultant, medical writer and Assistant Professor of Microbiology at Miami Dade College in Homestead, FL. She received her PhD in Biomedical Sciences from Meharry Medical College in Nashville, TN. She completed her postdoctoral training in Infectious Diseases at the University of Iowa in Iowa City, IA with a focus on the role of biofluid exosomes in inhibition of HIV infection. She has a wide range of research interests including retrovirology, parasitology, microbiology and immunology. Her research has focused on 1) elucidating mechanisms behind host restriction of HIV-1 infectivity and transmission and 2) discovery and development of small molecule and biological clinical candidates for antiretroviral biotherapeutic strategies. Her research has been supported by the NIH, Merck pharmaceuticals / UNCF and L’Oréal / AAAS / UNESCO and published in a number of peer-reviewed journals including Virology, Retrovirology, AIDS Research and Human Retroviruses, Infection and Immunityand Frontiers in Biosciences.
Retrovirology
Parasitology
Microbiology and Immunology
Her research has focused on 1) elucidating mechanisms behind host restriction of HIV-1 infectivity and transmission and 2) discovery and development of small molecule and biological clinical candidates for antiretroviral biotherapeutic strategies.